Clinical Trial Update: Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating venetoclax as consolidation therapy in chronic lymphocytic leukemia or small lymphocytic lymphoma patients on BTK inhibitor monoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | Phase 2 | Status: RECRUITING